Purchase Order 75N91025P00190

Award Date 2/7/25
Potential Completion Date 2/6/26
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $11,550.24, was issued by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health (NIH), to UK Biobank Limited, a non-profit organization based in the United Kingdom. The contract is for a 36-month extension to provide Tier 3 level access to UK Biobank's large-scale biomedical database, which contains de-identified genetic, lifestyle, and health information from over 500,000 participants in the UK. This...
This firm fixed-price purchase order contract was awarded by the National Eye Institute (NEI), a component of the National Institutes of Health (NIH), to UK Biobank Limited, a non-profit organization. The $11,630.34 contract provides access to UK Biobank's large-scale biomedical database containing genetic, lifestyle, and health information from over 500,000 UK participants. This biobank serves as a research resource for approved scientific studies, and the contract facilitates projects...
UK Biobank Limited has been awarded a $13,500 purchase order by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, to provide laboratory and testing services. The firm fixed price contract runs from December 2023 through March 2026 and will be performed by UK Biobank in Great Britain. No additional details were provided on the original solicitation or work scope. The award does not appear to be associated with a...
The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a $12,000 firm fixed price purchase order to UK Biobank Limited. The purpose of this contract is to provide Dr. Stewart and his team access to biobank data including whole exome and genome data on 500,000 individuals linked to electronic health records within UK Biobank. This will support analysis of the frequency, phenotypic spectrum, and penetrance...
This purchase order awards UK Biobank Limited $12,934.99 to provide Tier 3 access fees under a potential value of the same amount. As a non-profit organization, the contractor will deliver its standard biobank datasets and related laboratory and testing services to the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute in Bethesda, Maryland by November 14, 2024. The firm fixed price contract vehicle was awarded on November 15, 2023...
The National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism awarded UK Biobank Limited a three-year, firm fixed price purchase order valued at approximately thirteen thousand three hundred eighty-eight U.S. dollars to provide access to the United Kingdom Biobank dataset. As the prime contractor, UK Biobank Limited will deliver its biomedical database of genetic and health information to support research efforts of the National Institute on Alcohol Abuse and...
This is a firm fixed price purchase order awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to the United Kingdom's Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency. The contract provides the NCI with access to the Clinical Practice Research Datalink (CPRD) database and linkages to the National Cancer Data Registry, to support the NCI's epidemiological cancer research. Specific studies...
This firm fixed price Blanket Purchase Agreement (BPA) call award from the Department of Health and Human Services' National Institutes of Health's National Cancer Institute provides the prime contractor, the United Kingdom's Department of Health known as the Medicines & Healthcare Products Regulatory Agency, with a license to access the Clinical Practice Research Datalink (CPRD) National Cancer Data Registry (NCDR) database. Valued at one hundred seventy-three thousand one hundred...
This is a firm fixed price contract awarded by the Food and Drug Administration (FDA) to the Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency (MHRA), a UK government agency. The contract provides the National Institutes of Health's (NIH) National Cancer Institute with access to the UK Clinical Practice Research Datalink (CPRD) database of de-identified patient data, as well as linkages to other registries, to support the agency's...
This firm fixed price contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the United Kingdom's Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency. The $185,877.28 contract provides the NCI's Division of Cancer Epidemiology and Genetics (DCEG) with a one-year license to access the Clinical Practice Research Datalink (CPRD) medical records database, which contains...

This is a $12,120 firm fixed-price purchase order awarded by the National Cancer Institute, part of the National Institutes of Health, to UK Biobank Limited, a non-profit organization. The contract provides UK Biobank Limited's large-scale biomedical database containing de-identified genetic, lifestyle, and health information from over 500,000 UK participants as a research resource for approved scientific researchers to analyze. The award, with a completion date of February 6, 2026, facilitates access to the UK Biobank's datasets to support biomedical research on topics such as age-related diseases, heart/lung/blood disorders, cancer, alcoholism, and mental health. This purchase order does not involve any set-aside designation or subcontractors, reflecting UK Biobank Limited's specialized role as a leading provider of large-scale biomedical data.

Generated 2/5/25, 9:24 AM